Arglabin

Arglabin

CAT N°: 19502
Price:

From 74.00 62.90

Arglabin is a sesquiterpene ?-lactone originally isolated from A. glabella that has anticancer and anti-inflammatory activities.{45407} It inhibits the growth of LS-180, SSC-4, HeLa, MCF-7, and HL-60 cancer cells (IC50s = 20, 10, 20, 20, and 50 µM, respectively).{45408} Arglabin reduces tumor growth in an SCC-4 mouse xenograft model when administered at a dose of 40 µg/g. It is a selective inhibitor of the NLRP3 inflammasome over the NLRP1, AIM2, and NLRC4 inflammasomes when used at a concentration of 50 nM.{45407} Arglabin (50 nM) reduces increases in protein levels of NLRP3, caspase-1, IL-1?, and IL-18 induced by cholesterol crystals in LPS-primed mouse peritoneal macrophages. It decreases plasma levels of IL-1?, oxidized LDL autoantibodies, total cholesterol, and triglycerides, and reduces the size of atherosclerotic lesions in the aorta of mice fed a high-fat diet when administered at a dose of 2.5 ng/g.

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • (3aR,4aS,6aS,9aS,9bR)-5,6,6a,7,9a,9b-hexahydro-1,4a-dimethyl-7-methylene-3H-oxireno[8,8a]azuleno[4,5-b]furan-8(4aH)-one
  • Correlated keywords
    • (+) Arglabine antitumor Magnolia grandiflora protein lipidation anti-cancer antiinflammatory LS180 SSC4 He-La MCF7 HL60 NLRP-3 1 AIM-2 NLRC-4 IL1? IL18 macro-phages auto-antibodies
  • Product Overview:
    Arglabin is a sesquiterpene ?-lactone originally isolated from A. glabella that has anticancer and anti-inflammatory activities.{45407} It inhibits the growth of LS-180, SSC-4, HeLa, MCF-7, and HL-60 cancer cells (IC50s = 20, 10, 20, 20, and 50 µM, respectively).{45408} Arglabin reduces tumor growth in an SCC-4 mouse xenograft model when administered at a dose of 40 µg/g. It is a selective inhibitor of the NLRP3 inflammasome over the NLRP1, AIM2, and NLRC4 inflammasomes when used at a concentration of 50 nM.{45407} Arglabin (50 nM) reduces increases in protein levels of NLRP3, caspase-1, IL-1?, and IL-18 induced by cholesterol crystals in LPS-primed mouse peritoneal macrophages. It decreases plasma levels of IL-1?, oxidized LDL autoantibodies, total cholesterol, and triglycerides, and reduces the size of atherosclerotic lesions in the aorta of mice fed a high-fat diet when administered at a dose of 2.5 ng/g.

We also advise you